Related references
Note: Only part of the references are listed.Phase 2a Pharmacokinetic, Safety, and Exploratory Efficacy Evaluation of Oral Gepotidacin (GSK2140944) in Female Participants with Uncomplicated Urinary Tract Infection (Acute Uncomplicated Cystitis)
J. Scott Overcash et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Pharmacokinetics of Gepotidacin in Renal Impairment
Mohammad Hossain et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2020)
Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase
Elizabeth G. Gibson et al.
ACS INFECTIOUS DISEASES (2019)
1482. Microbiological Analysis from a Phase II Study Evaluating Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections
Nicole Scangarella-Oman et al.
Open Forum Infectious Diseases (2019)
731. Pharmacokinetics of Gepotidacin (GSK2140944) in Subjects with Hepatic Impairment
Jonathan T Hands et al.
Open Forum Infectious Diseases (2019)
Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation
Stephanie N. Taylor et al.
CLINICAL INFECTIOUS DISEASES (2018)
In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae
Susanne Jacobsson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Microbiological Analysis from a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae
Nicole E. Scangarella-Oman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections
William O'Riordan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
A Phase I, Randomized, Double-Blinded, Placebo- and Moxifloxacin-Controlled, Four-Period Crossover Study To Evaluate the Effect of Gepotidacin on Cardiac Conduction as Assessed by 12-Lead Electrocardiogram in Healthy Volunteers
Mohammad Hossain et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae
D. J. Farrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The metabolism and disposition of GSK2140944 in healthy human subjects
Kitaw Negash et al.
XENOBIOTICA (2016)
In Vitro Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens
D. J. Biedenbach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Type IIA topoisomerase inhibition by a new class of antibacterial agents
Benjamin D. Bax et al.
NATURE (2010)
Share Paper
